Krystal Biotech Announces Virtual Presentation of Pre-clinical Data on KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency at ESGCT. PITTSBURGH, Oct. 14, 2021 (GLOBE NEWSWIR …
( read original story …)